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Neglected Tropical Diseases and 
Equity in the Post-2015 Health 
Agenda*
Emma Michelle Taylor and James Smith
Abstract The Millennium Development Goals’ focus on just three infectious 
diseases (HIV/AIDS, malaria, and belatedly, tuberculosis) configured the 
global health funding landscape for 15 years. neglected tropical diseases 
(NTDs), a group of 17 or so diseases that disproportionately afflict the 
world’s ‘bottom billion’, are a symbol of global health inequities, in terms of 
prioritisation, research attention, and treatment. This article traces efforts 
to include NTDs in the Sustainable Development Goal (SDG) agenda and, 
having achieved that goal, lobby for an influential position in the post-2015 
aid agenda. The SDGs herald a shift to a more expansive approach and 
there is a risk that NTDs will once again be left behind, lost in a panoply of 
new goals and targets. There is, however, an opportunity for NTDs to lever 
their ‘neglect’ and be recast as a tool of accountability, acting as both a 
target for and proxy indicator of health equity for the SDGs.
Keywords: NTDs, SDGs, MDGs, global health, evidence, indicators, 
health policy.
1 Introduction
‘To fulfil our vision of  promoting sustainable development, we must 
go beyond the MDGs. They did not focus enough on reaching the 
very poorest and most excluded people…’ 
A New Global Partnership: Eradicate Poverty and Transform Economies 
through Sustainable Development. The Report of  the High-Level Panel of  
Eminent Persons on the Post-2015 Development Agenda, High-Level Panel 
of  Eminent Persons on the Post-2015 Development Agenda 2013, 
page i
‘The NTD agenda… is fundamentally aligned with the SDG 
commitment to leave no one behind’.  
Integrating Neglected Tropical Diseases into Global Health and Development: 
Fourth WHO Report on Neglected Tropical Diseases, World Health 
Organization, 2017, page 66
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Equity and inclusion are threads running through the Sustainable 
Development Goals (SDGs). The goals are conceptualised as both a 
pathway to equity and as targets that cannot be sustainably achieved 
without being built on an equitable base. The jump from eight 
Millennium Development Goals (MDGs) to 17 SDGs underpinned by a 
range of  sub-goals, and the devolution of  the delivery of  goals down to 
nation states is welcome, and is partly a byproduct of  more accountable 
notions of  development. While the SDGs present a fuller and more 
grounded concept of  development and how it might be achieved, they 
present significant challenges: firstly, for how one counts, and accounts 
for, ‘progress’; and secondly, for who is responsible for progress. This 
is perhaps especially true for global health, where the institutional 
landscape is particularly complex: the MDGs cast a long shadow, 
increasing funding for certain diseases and often-vertical programmes; 
state and non-state actors have proliferated; and demands for 
transparency and accountability have driven calls for better evidence, 
policy, and practice.
Global development goals – whether they be millennium or sustainable 
– are fundamental to questions of  accountability and equity for 
global health. The transition from the MDGs in 2000 to the SDGs 
in 2015 was a febrile time for health advocacy as intense lobbying 
sought to create new goals to reflect new priorities and aspirations 
(Buse and Hawkes 2015). In this article, we use the case of  neglected 
tropical diseases (NTDs) to reflect on the relationships between equity, 
accountability, and priority in global health. The NTDs, a group of  17 
or so diseases that, it is argued, especially within the NTD community, 
disproportionately afflict the world’s ‘bottom billion’ (Collier 2007), 
are a symbol of  health inequities, in terms of  prioritisation, research 
attention, and treatment (see Box 1; also Hotez et al. 2014). This article 
tracks the course of  ostensibly successful lobbying for these diseases to 
Box 1 Neglected tropical diseases
Neglected tropical diseases (NTDs) are a group of  parasitic 
and bacterial infections which are usually endemic in 
low-income populations in Africa, Asia, and the Americas. 
They affect over 1 billion people and are a significant disease 
burden. Populations living in poverty, without adequate 
sanitation, and in close proximity to vectors and livestock 
are amongst the most vulnerable. Some NTDs have known 
preventative measures or medical treatments – there may 
be a problem of  access. These include: schistosomiasis; soil 
transmitted helminthiasis; lymphatic filariasis; onchocerciasis; 
trachoma. Some require new tools – drugs, diagnostics, and 
control measures. These include: leishmaniasis; Chagas’ 
disease; human African trypanosomiasis (HAT).
Source: WHO (2010).
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receive special attention in the post-2015 agenda (cf. Smith and Taylor 
2013, 2016). The SDGs herald a shift to a more expansive approach to 
development, but there is a risk that the NTDs could fail to gain traction 
in the new agenda, lost in a panoply of  goals and targets. There is also, 
conversely, an opportunity for the NTDs to lever their earlier ‘neglect’ 
and be recast as tools of  accountability – to act as both a primary target 
for, and a proxy indicator of, health equity in the framework. In this 
article, we highlight the politics that have struggled to place the NTDs 
centre stage, partly by recasting them as indicators of  equity in the 
post-2015 agenda, as a means to reflect on what the shift to SDGs may 
mean for accountability.
2 Why the MDGs?
Prior to the time-bound goals and related targets established by the 
Millennium Declaration in 2000 (United Nations 2000), a striking feature 
of  development diplomacy in the twentieth century was the tendency of  
governments to rehash the same vague commitments time and again, 
without recourse. A key example of  what William Easterly has labelled 
the ‘historical amnesia’ (2002: 49) of  the development industry was 
the pledge that governments would provide 0.7 per cent of  their gross 
national product as official development assistance (ODA). Originally 
set as a target in 1970, it took 45 years for the UK to honour the UN aid 
commitment. When it did, it became the first G7 country to do so. There 
are countless other examples of  unmet development pledges – the point 
being that for much of  development’s history, there was no consequence 
for aid donors who chose to promise one thing, then do another.
The MDGs, then, marked a sea change in how development was 
approached. Galvanised by the seeming simplicity of  tackling 
‘development’ via eight narrowly focused, time-bound goals (as tracked 
through 18 targets and 48 technical indicators), the international 
community showed commitment to delivering on the MDGs in a 
manner not witnessed before. Data collection methods were devised, 
and data systems built to provide the evidence needed to track progress 
against the goals. To support the goals, new resources were leveraged, 
and dedicated aid-disbursement initiatives such as the Global Fund 
to Fight AIDS, Tuberculosis and Malaria (GFATM) were established 
to increase the likelihood that goals would be met on time. In 2005, 
the Paris Declaration on Aid Effectiveness set out five principles 
that helped to further align and harmonise aid to focus on results 
and accountability (OECD 2005). A sea change in the delivery of  
development was emerging, theoretically at least. It is significant that 
the adoption of  the MDGs came at the end of  a decade in which the 
purpose and usefulness of  official development aid had come under 
increased scrutiny. A changing political climate in the 1990s, coupled 
with the poor results of  decades of  work and billions of  dollars aimed 
at improving social and economic conditions in poor countries, led to 
a questioning of  the effectiveness of  aid and development practices 
(Riddell 2007). In response, there was a renewed appetite to make aid 
work for development.
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The MDGs gave a new prominence to the health issues affecting 
poor populations. However, their focus was narrow and derived from 
top-down deliberation rather than broader participatory approaches. 
Consequently, the narrowness of  the MDGs left gaps in coverage, 
and failed to realise potential synergies between the discrete foci of  
the goals (education, health, poverty, and gender) (Waage et al. 2010). 
MDG 6, in particular – combat HIV/AIDS, malaria and other diseases – 
effectively sidelined many of  the communicable and non-communicable 
diseases that perpetuate the cycle of  poverty in developing countries 
(including the NTDs). Conversely, singling out HIV/AIDS and 
malaria within MDG 6 raised the profile of  these diseases, stimulating 
a reconfiguration and refocusing of  ODA for health. Global health 
initiatives such as the GFATM and the President’s Emergency Plan 
for AIDS Relief  (PEPFAR) ushered in an era of  vertical aid on an 
unprecedented scale, diverting resources away from existing health 
programmes (Shiffman 2008). In a funding climate of  narrowing focus, 
advocacy groups were left to argue that it was their disease being referred 
to in the ambiguous wording: ‘other diseases’.1
3 Establishing the NTDs – fighting for a voice
The 17 NTDs identified by the World Health Organization (WHO) in 
2010 represented some of  the MDGs’ ‘other diseases’. Their neglected 
tag stems from the disparity between the attention and funding they 
receive (0.6 per cent of  ODA for health), and their large impact in terms 
of  Disability-Adjusted Life Years (DALYs) (Liese and Shubert 2009; 
Murray et al. 2012). The NTDs are repeatedly identified as drivers of  
poverty (Durrheim et al. 2004), undermining efforts to meet a host of  
development goals and targets through an erosion of  people’s ability to 
live, thrive, and work (Hotez et al. 2006; Global Network 2013). In the 
context of  the MDGs, the narrow focus of  the goals, the health goal 
in particular, tended to drive a siloed approach to interventions. The 
consequent lack of  emphasis on the interrelationships between the goals 
limited concerted efforts to focus on the NTDs.
The omission of  NTDs from the MDGs led to a group of  concerned 
stakeholders working hard to place NTDs firmly on the international 
agenda. The emergence of  a global alliance of  stakeholders – ranging 
across the gamut of  global health actors – mobilised to raise the profile 
of  NTDs (Smith and Taylor 2013). Progress was swift: in 2003, the 
Drugs for Neglected Diseases initiative (DNDi) and the Foundation 
for Innovative Diagnostics (FIND) were established. In 2010, WHO 
released its First Report on the NTDs, pinning down the disparate 17 
diseases we now know by the shorthand ‘NTDs’ (WHO 2010).2 Progress 
was such that the then WHO Secretary-General, Dr Margaret Chan, 
somewhat ironically described the story of  the NTDs in the twenty-first 
century as one of  ‘rags to riches’ (Chan 2012), given the great efforts 
expended to intrinsically link tackling the NTDs to pulling the ‘bottom 
billion’ out of  poverty (Hotez et al. 2009).
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4 The NTDs and the SDGs – leaving no one behind
On 1 January 2016, the SDGs came into force. The particulars of  
the goals were finalised at the UN summit in September 2015, with 
the NTDs gaining a special mention in SDG 3.3: ‘By 2030, end the 
epidemics of  AIDS, tuberculosis, malaria and neglected tropical diseases 
and combat hepatitis, water-borne diseases and other communicable 
diseases’ (United Nations General Assembly 2015: 16). The decade-long 
effort of  the NTD lobby had been successful, they had ‘won’.
While it was important to be name-checked, and have one’s seat at 
the global goal table, it was apparent that the SDGs were to be quite 
different from the MDGs. A recurrent critique of  the MDGs was that 
they were restricted in focus and conceived of  by committee. This cannot 
be levelled at the SDGs, which were the result of  an extensive three-year 
consultation, involving multiple perspectives from government, civil 
society, expert groups, the private sector, and individuals. Instead of  eight 
goals, there are now 17 accompanied by 169 targets. Has the High-
Level Panel which originally drafted the framework document been 
ignored? ‘The international community will need to ensure that a single, 
sustainable framework agenda is not overloaded with too many priorities. 
A product of  compromise rather than decisions…’ (HLP 2013: 14).
The post-2015 vision – enacted through the SDGs – is to create a single 
universal agenda in which the social, economic, and environmental 
dimensions of  sustainability are integrated, underpinned by the tenet 
‘leave no one behind’ (HLP 2013: 7). This tenet presents an opportunity 
for the NTDs.
5 Framing the NTDs as cross-cutting
The success of  a name-check in SDG 3.3 was tempered by extensive 
references to other health concerns, as detailed in the overarching 
Goal 3: Ensure healthy lives and promote wellbeing for all at all ages. Goal 3 is 
accompanied by nine targets and four means of  implementation, and 
covers everything from maternal health to non-communicable diseases 
and traffic accidents. There is a risk of  the NTDs disappearing amongst 
a panoply of  other targets.
For those concerned with tackling NTDs, there is also a pressing 
financial need for NTDs to gain greater prominence and policy traction 
if  they are to be effectively addressed. Current funding commitments for 
the NTDs (from various sources including ODA, philanthropic giving, 
and national budgets) for the period 2015–20 have been projected at 
less than US$200 million a year;3 yet WHO has suggested that the total 
investment needed to support the NTD Roadmap for the 2015–20 
period is US$18 billion (WHO 2015a: 24). This is a problematic 
disparity, yet one that could feasibly be lessened by the NTDs’ impact 
being emphasised across the SDG framework. As editor of  The Lancet, 
Richard Horton, has suggested: ‘Unless high-level political recognition 
is given to NTDs by their inclusion in new development goals, the 
financing to meet WHO’s targets is unlikely to materialise’ (ibid.: 758).
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The NTD lobby has, unsurprisingly given its genealogy, been proactive 
in formulating a case that the NTDs should be anchored across the 
broader SDG agenda, whether that be rhetorically (the argument that 
the NTDs are both outcomes and drivers of  poverty has already been 
rehearsed (Durrheim et al. 2004)), by partnering directly with other 
agendas such as water and sanitation for health (WHO 2015b), or by 
proxy, by suggesting the NTDs should be used as tracer indicators for 
other SDG targets (Smith and Taylor 2016).
The recently retired director of  the WHO Department of  Control of  
Neglected Tropical Diseases, Dirk Engels, has argued that it is necessary 
to use the NTDs as ‘tracers’ (or proxy indicators) for a number of  other 
SDG targets, such as Universal Health Coverage (SDG 3.8) and access 
to safe water (SDG 6.1) to monitor equity in the post-2015 agenda, 
‘precisely because NTD endemic populations are the least likely to have 
access to these services at present’ (Engels 2016: 224). In this manner, 
the burden of  NTDs is suggested as ‘a proxy for inequitable access to 
the systems – especially health systems – through which people improve 
their health and wealth’ (WHO 2015a: 12), and Universal Health 
Coverage (UHC) depicted as ‘one of  the most powerful social equalizers 
among all policy options’ (Margaret Chan, cited in WHO 2015a: x).
In WHO’s fourth Report on NTDs – Integrating Neglected Tropical Diseases 
into Global Health and Development – the case is made that ‘tackling NTDs 
significantly improves the prospects of  attaining all of  the SDGs, from 
reducing poverty and malnutrition to improving water and sanitation, 
gender equality and education’ (WHO 2017: 66). Specifically, it has 
been argued by the NTD lobby that NTDs directly impact on six of  the 
17 SDGs.4 Although even outside those goals, ‘more subtle’ alignments 
and potential synergies are hinted across the broader framework 
(WHO 2017: 68; also see Bangert et al. 2017 for a fuller discussion on all 
the ways the NTDs are argued to impact on the SDG framework).
The underpinning importance of  the NTDs for the attainment of  a 
wider range of  SDGs is repeatedly stressed by adherents. Moreover, 
a value-for-money argument is supported by creating the logic that 
investment in the NTDs could maximise returns across a broad range 
of  SDG goals and targets – a point Dirk Engels has been quick to stress:
I do not share the opinion that the main outcome for the inclusion of  
the NTDs within the Sustainable Development Goals would be more 
money for the NTDs. Inclusion of  NTD indicators and tracers will, 
on the contrary, help to maximise returns on investments in a broad 
portfolio of  Sustainable Development Goal targets (2016: 224).
WHO’s most recent report on the NTDs suggests NTD interventions 
could act as ‘tracers of  equity’ in relation to six goals and eight targets 
(WHO 2017). Effectively, NTDs are being framed as both a target for, and 
an indicator of  equity in the new SDG framework.
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6 Lobbying for primary and proxy indicators
Increasing demands for accountability for health present both a 
challenge and an opportunity for the NTD lobby (Smith and Taylor 
2016). If  accountability drives increasing demands for targets and 
evidence to measure progress against those targets, it is vital for 
NTDs to secure indicators if  they are to access resources and marshal 
activity. The indicator that most concerns the NTD community seeks 
to measure the ‘number of  people requiring interventions against 
neglected tropical diseases’ (IAEG-SDG 2015: 9). In theory, these data 
could be collected from a number of  existing sources (for example, 
accounting for donated medicines for preventative chemotherapy or 
results from active screening for disease) to inform an overarching 
indicator. There is, in fact, no precedent for collecting these kinds of  
data systematically or universally, and WHO admits to several data gaps 
in the current NTD reporting systems (2017).
Thanks in part to their inclusion in the MDGs, the ‘big three’ diseases 
already boast indicators with proven data collection methodologies. 
The NTDs are not so well endowed, with the groups addressing the 
17 diseases tending to affect the people who live outside the formal 
health-care systems now being tasked with tracking interventions. 
To address the data gaps, WHO has suggested that a comprehensive 
information management system will need to be developed. This would 
be a mammoth task but one that helps underline the SDG’s equity focus:
The NTD indicator [for SDG target 3.3] counts, and thus renders 
visible for the first time the more than one billion people estimated 
to require treatment and care for NTDs… this indicator will drive 
efforts and in some cases build from the beginning, systems that will 
greatly improve the lives of  neglected populations (WHO 2017: 108).
The NTD indicator can help focus attention on neglected populations; 
a need for data can prompt the development of  systems to count and 
assess activity and impact. NTD proxy or tracer indicators can do more 
than that, helping to build health systems. For this reason, arguments 
are being made in favour of  an NTDs tracer being adopted as an 
indicator for SDG 3.8 on UHC.5
UHC has been defined as ensuring that all people have access to needed 
promotive, preventative, curative, and rehabilitative health services, of  
sufficient quality to be effective, while also ensuring that people do not 
suffer financial hardship when paying for these services (WHO 2015c). 
UHC needs to be understood within country contexts, the reality and 
ambition of  health-care service coverage being limited by funding, 
capacity, and often political will. Regardless of  income, virtually every 
country strives to provide greater health-care service coverage, hence 
‘the UHC endeavour is generally referred to as a journey rather than a 
destination, as a dynamic, continuing process rather than a permanent 
solution or state that can be achieved’ (WHO 2017: 87).
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Of  all the SDG targets that the WHO department for NTDs has 
determined could benefit from NTD tracers, UHC is the one it has 
attached the most importance to. It argues that this is because ‘UHC 
is the only target that binds all of  the targets of  the health goal, as well 
as addressing linkages with health-related targets in the other goals’ 
(WHO 2017: 85). In short, UHC, much like the NTDs themselves is 
viewed as cutting across the SDG agenda, and pivotal to the success 
of  several goals. This effectively allows NTDs to not only directly 
piggyback on certain goals but also potentially interact with other goals 
indirectly via UHC, should it indeed become a proxy indicator.
Due to the complex nature of  UHC – which presents a shifting target, 
and one that will not look the same in every context – it is acknowledged 
that measuring progress towards SDG 3.8 will prove very challenging. 
There cannot therefore be one indicator, but many – all effectively proxies/
tracers – that will serve to track people’s ability to access a basic package of  
health-related interventions and services. Moreover, the precise composition 
of  this package will differ by country to reflect the context-specific health 
priorities at play. Despite this, and in order to help assess regional and global 
progress towards the UHC target, WHO has determined that it would be 
helpful to identify a set of  tracer indicators that could then be combined 
to form a monitoring index. To date, 16 tracer indicators (things like child 
immunisation and HIV treatment) have been adopted and grouped under 
the four categories of: reproductive, maternal, newborn, and child health; 
infectious diseases; non-communicable diseases; service capacity and access; 
and health security. So far, no NTD interventions have been included in 
the UHC coverage index. Nevertheless, WHO has developed an ‘NTD 
coverage index’ based on the coverage of  preventative chemotherapy for 
five of  the NTDs, and continues to campaign for its adoption. In short, 
the campaigning around the NTDs’ meaningful inclusion in the SDG 
framework continues, with WHO arguing that ‘it is clear that monitoring 
NTD coverage could still make a significant contribution to tracking the 
coverage of  essential health services’ (WHO 2017: 117).
7 Discussion: not forgetting what is left behind
The changing relationship between the NTDs and Global Goals 
highlights the dynamics of  the relationship between accountability and 
global health, which help us problematise and reframe current notions 
of  accountability. Bruen et al. (2014: 12) argue that ‘accountability is a 
frequently invoked though arguably less questioned concept in global 
health operation’. Accountability is rather more complex than one actor 
holding another to account; rather, it is a dynamic process that shapes 
and is shaped by relationships between increasingly diverse sets of  
actors, and framed by priorities, data, and evidence.
The reference to NTDs within a Global Goal and the realities of  the 
transition from MDGs to SDGs highlights dimensions of  accountability 
that warrant further analysis if  we are to develop more transparent, 
participatory, and equitable methods of  delivering a transformational 
global health agenda.
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The MDGs were criticised as being top-down, too narrowly focused, 
and too disconnected from each other. The emergence of  the SDGs are 
themselves a recognition of  this, specifically recognising the interactions 
between goals (one of  the proposed selling points of  the NTDs) and 
greatly broadening our conceptions of  health and development, as 
well as developing a broader sense of  who is responsible for delivering 
on them (Buse and Hawkes 2015). The SDGs are also a reflection of  
broader shifts in development thinking, towards holistic, integrated, 
intersectoral, indivisible goals for which the responsibility of  delivering 
is collective. Equity is conceived of  as both an overarching aspiration 
and a prerequisite for delivering the goals. The potential place of  the 
NTDs within an SDG-inflected world presents important implications 
for accountability with regard to global health.
Firstly, the NTDs highlight practical challenges for accountability: how 
are priorities set and how is progress measured? There is an emphasis on 
countries to set their own targets that reflect their national circumstances. 
The concentration of  NTDs in less-developed countries, which typically 
have less capacity to deliver the sorts of  systematic interventions 
necessary to, for example, deliver active disease screening or mass drug 
administration, presents a challenge, and suggests that tough decisions 
around priorities and programmes have to be made. This may be viewed as 
an opportunity for NTDs, given their connections to other goals and targets 
and potential to act as proxies of  progress, thus cementing investment and 
focus. At this stage, however, it is unclear whether increased efforts aimed at 
controlling NTDs may supplement or complement broader efforts to map, 
measure, and tackle global health concerns, or whether NTDs may become 
again lost in a panoply of  priorities in resource-constrained settings.
Secondly, the cross-cutting nature of  the SDGs and NTDs in particular 
suggests complications around the who of  accountability. Cross-cutting 
approaches to NTD control, often but not always embedded in national 
contexts, require broader sets of  actors, including the private sector 
in, for example vector control, or local communities with regard to 
mass drug administration. There are of  course many examples of  
intersectional approaches to dealing with health and development issues, 
but the broadening of  the ambitions of  the SDG agenda suggest both a 
broadening of  responsibility to deliver against that agenda and attendant 
issues around which countries, agencies, and actors will be held to account.
There is a risk that accountable practices, so important to the thinking 
behind the concept of  Global Goals and central to the delivery of  the 
SDGs, will become lost or unimplementable amongst the white noise of  
multiple goals and targets. Accountability may suffer from the technical 
perspective of  difficulties in measuring progress across complex 
topographies of  goals, targets, and nations; from the conceptual 
perspective of  truly understanding how interventions interact between 
goals and targets; and from the ethical perspective of  whom can 
legitimately be held to account when so many are involved in delivery.
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The NTDs underline some of  the problems of  accountability in the 
emerging SDG era. A more complex, nuanced, and ambitious global 
health and development agenda requires new ways of  doing things. 
There are technical and conceptual challenges, which may be partially 
addressed by new technologies and data sets that can map progress and 
shed light on the relationships and trade-offs between economic, social, 
and environmental development. There are issues of  ethics and equity, 
who is responsible for what, and how priorities are arrived at. This may 
be more difficult to address, and involves us reflecting on just who is 
responsible for delivering development. Plural pronouns are powerful, 
but are they organisationally useful?
The NTDs themselves, until recently hidden in the netherworld of  
global health, can act as a mirror to accountability. For many years 
unprioritised, recently recognised, with ambitious elimination plans not 
yet realised (or accounted for). Their attraction is partly that they are 
multipurpose, they are a global target and may be adopted as a useful 
proxy indicator. This attractiveness highlights some of  the immense 
difficulty of  realising accountability in the new era of  complex, multiple, 
connected goals and associated indicators. We should not forget that 
NTDs are diseases of  poverty: controlling and treating them will 
improve lives and livelihoods and help progress towards equity, and as 
the SDGs assert, this is a concern for all of  us.
Notes
*  This article results from research funded by the European 
Research Council (Investigating Networks of  Zoonosis Innovation, 
Project ID: 295845).
1 It is noteworthy that tuberculosis was able to transcend ‘other 
diseases’ through its close association with HIV/AIDS, as witnessed 
in the focus of  the GFATM. It showed that lobbying and making 
associations could shape discourses and influence priorities around 
global health.
2 Note that in 2017, the list of  NTDs has been enlarged to include 
chromoblastomycosis and other deep mycoses, scabies and other 
ectoparasites, and snakebite envenoming.
3 Not including in-kind donations of  drugs.
4 Goal 1: End poverty in all its forms everywhere; Goal 2: End 
hunger, achieve food security and improved nutrition and promote 
sustainable agriculture; Goal 3: Ensure healthy lives and promote 
wellbeing for all at all ages; Goal 4: Ensure inclusive and equitable 
quality education and promote lifelong opportunities for all; Goal 6: 
Ensure availability and sustainable management of  water and 
sanitation for all; Goal 11: Make cities and human settlements 
inclusive, safe, resilient and sustainable (WHO 2017: 68).
5 While indicator 3.8 is the most important, WHO is also making a 
similar case for NTD ‘tracers of  equity’ to help monitor six SDGs 
and eight targets (WHO 2017: 119).
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